Prevalence and Patterns of Smoking in South Korea

Oct.24.2022
Prevalence and Patterns of Smoking in South Korea
Researchers at Seoul National University Hospital found that South Korean men are using more heated tobacco products than e-cigarettes.

A team led by Professor Cheol-Min Lee of the Department of Family Medicine at Seoul National University Hospital conducted a study surveying 6,188 adult males and females aged 19 and over who participated in the 2019 National Health and Nutrition Examination Survey. The overall usage rate (smoking rate) of traditional cigarettes, electronic cigarettes, and heated cigarettes among adults was 19% (1,181 people). Of each type of cigarette use, traditional cigarettes (34.7% for males, 5.9% for females) had the highest usage rate, followed by heated cigarettes (8.8% for males, 1.5% for females) and electronic cigarettes (4.3% for males, 1.0% for females).


The usage of heated tobacco products in South Korea, which were introduced in 2017, is almost double the usage of e-cigarettes, which were first introduced in 2003. Among heated tobacco product users, only 23.6% use one type, while 58.0% use two types (regular cigarettes or e-cigarettes) and 18.4% use all three types. Since their introduction, e-cigarettes have posed various potential risks to human health. Heated tobacco products, which were first launched in 2014, are rapidly gaining market share. According to Euromonitor International's 2019 data, the largest heated tobacco product markets in the world are Japan ($8.6 billion), South Korea ($1.6 billion), and Italy ($1 billion). Although users claim a lower dependence and poorer health status compared to smokers, many facts about their impact on human health remain unknown.


The findings of this study were published in the latest English journal of the Korean Society of Family Medicine and presented at the Korea Food Exchange Forum (KOFRUM).


Statement:


This article is compiled from third-party sources for industry professionals to exchange and learn from.


This article does not express the views of 2FIRSTS and 2FIRSTS cannot confirm the truthfulness or accuracy of the article's content. The translation of this article is only intended for industry-related communication and research purposes.


Due to limitations in the translator's ability, the translated article may not fully reflect the original. Please refer to the original article for accuracy.


4. 2FIRSTS maintains complete alignment with the Chinese government regarding any domestic, Hong Kong, Macau, Taiwan, or foreign-related statements and positions.


The copyright of the compiled information belongs to the original media and author(s). If there is an infringement, please contact us to request deletion.


This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

Hungary’s Continental Tobacco Launches New Slay Nicotine Pouch Brand in UK Targeting Female Consumers
Hungary’s Continental Tobacco Launches New Slay Nicotine Pouch Brand in UK Targeting Female Consumers
Hungary’s Continental Tobacco Group has launched its Slay nicotine pouch brand in the UK, featuring compact, pastel-toned packaging and backed by a multi-million-pound investment and retail pilot programme to build its presence in the local market.
Dec.03 by 2FIRSTS.ai
Altria and NJOY Sue ITC, Claim Judge Appointment Process Is Unconstitutional
Altria and NJOY Sue ITC, Claim Judge Appointment Process Is Unconstitutional
Altria Group and its NJOY subsidiary have filed a lawsuit in Virginia federal court challenging the U.S. International Trade Commission’s process for appointing administrative law judges. The companies allege the system violates the U.S. Constitution and seek to halt an ITC patent investigation initiated by rival Juul.
Nov.10
U.S. FDA Unveils Next-Generation Agentic AI Tool to Boost Review and Regulatory Efficiency
U.S. FDA Unveils Next-Generation Agentic AI Tool to Boost Review and Regulatory Efficiency
The U.S. FDA has announced the agency-wide deployment of new agentic AI capabilities, providing all employees with an optional multi-step task automation tool. Building on the broad adoption of its earlier large-language-model system, Elsa, the FDA aims to use this next-generation AI workflow to accelerate product review, regulatory oversight, and internal operations, while maintaining strict human supervision and data security.
Dec.02 by 2FIRSTS.ai
84% of Britons Back Regulation of Nicotine Pouches, Survey Finds
84% of Britons Back Regulation of Nicotine Pouches, Survey Finds
A Northerner survey finds 84% of Britons support regulating nicotine pouches and 82% back a licensing scheme for vape sales, aligning with the Tobacco and Vapes Bill to improve consumer safety and youth protection.
Nov.06 by 2FIRSTS.ai
Nicotine Pouch Brand VELO and McLaren Unveil Special Livery for the Abu Dhabi Grand Prix
Nicotine Pouch Brand VELO and McLaren Unveil Special Livery for the Abu Dhabi Grand Prix
According to PRNewswire, VELO and the McLaren Formula 1 Team have unveiled a special livery for the Abu Dhabi Grand Prix, co-created by nine superfans from around the world. The design forms the highlight of the “Live Your Fandom” campaign, reflecting memorable fan stories and celebrating the global McLaren community.
Dec.04 by 2FIRSTS.ai
ceshi1111
ceshi1111
Trusted by industry leaders and innovators, ARAC brings unmatched expertise in Modules 5 & 6, including label and claim development, comprehension testing, human factors/usability, and clinical-behavioral research such as actual use and switching studies. These studies generate the robust, real-world evidence needed to evaluate whether products are “Appropriate for the Protection of Public Health” (APPH) -- including randomized experimental longitudinal, actual use, cohort st
Oct.21